{"id":"https://openalex.org/W1995282014","doi":"https://doi.org/10.1158/1538-7445.pedcan-a41","title":"Abstract A41: Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma","display_name":"Abstract A41: Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma","publication_year":2014,"publication_date":"2014-10-09","ids":{"openalex":"https://openalex.org/W1995282014","doi":"https://doi.org/10.1158/1538-7445.pedcan-a41","mag":"1995282014"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.pedcan-a41","doi":"https://doi.org/10.1158/1538-7445.pedcan-a41","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.pedcan-a41","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019170764","display_name":"Adam Kie\u017cun","orcid":"https://orcid.org/0000-0002-6634-1073","observed_orcids":["https://orcid.org/0000-0002-6634-1073"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam Kiezun","raw_affiliation_strings":["1Broad Institute, Cambridge, MA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Broad Institute, Cambridge, MA,","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009695700","display_name":"Jennifer A. Perry","orcid":"https://orcid.org/0009-0003-2636-0952","observed_orcids":["https://orcid.org/0009-0003-2636-0952"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Perry","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, MA,","2Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA,","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"2Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085234863","display_name":"Peter Tonzi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Tonzi","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, MA,","2Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA,","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"2Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039044023","display_name":"Eliezer M. Van Allen","orcid":"https://orcid.org/0000-0002-0201-4444","observed_orcids":["https://orcid.org/0000-0002-0201-4444"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eliezer Van Allen","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, MA,","2Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA,","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"2Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024772763","display_name":"Scott L. Carter","orcid":"https://orcid.org/0000-0002-8480-1475","observed_orcids":["https://orcid.org/0000-0002-8480-1475"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott L. Carter","raw_affiliation_strings":["1Broad Institute, Cambridge, MA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Broad Institute, Cambridge, MA,","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055785210","display_name":"Sylvan C. Baca","orcid":"https://orcid.org/0000-0002-4087-8606","observed_orcids":["https://orcid.org/0000-0002-4087-8606"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sylvan Baca","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, MA,","2Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA,","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"2Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080667439","display_name":"Ami Siddharth Bhatt","orcid":"https://orcid.org/0000-0001-8099-2975","observed_orcids":["https://orcid.org/0000-0001-8099-2975"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ami Bhatt","raw_affiliation_strings":["1Broad Institute, Cambridge, MA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Broad Institute, Cambridge, MA,","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070808897","display_name":"Michael S. Lawrence","orcid":"https://orcid.org/0000-0002-1307-459X","observed_orcids":["https://orcid.org/0000-0002-1307-459X"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Lawrence","raw_affiliation_strings":["1Broad Institute, Cambridge, MA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Broad Institute, Cambridge, MA,","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020222350","display_name":"Loren D. Walensky","orcid":"https://orcid.org/0000-0002-0869-2334","observed_orcids":["https://orcid.org/0000-0002-0869-2334"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Loren Walensky","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, MA,","2Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA,","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"2Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068721624","display_name":"Nikhil Wagle","orcid":"https://orcid.org/0000-0003-3332-9438","observed_orcids":["https://orcid.org/0000-0003-3332-9438"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil Wagle","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, MA,","2Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA,","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"2Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075358445","display_name":"Jaume Mora","orcid":"https://orcid.org/0000-0002-9386-5980","observed_orcids":["https://orcid.org/0000-0002-9386-5980"]},"institutions":[{"id":"https://openalex.org/I1307323311","display_name":"Hospital Sant Joan de D\u00e9u Barcelona","ror":"https://ror.org/001jx2139","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I1307323311"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jaume Mora","raw_affiliation_strings":["3Hospital Sant Joan de Deu, Barcelona, Spain,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Hospital Sant Joan de Deu, Barcelona, Spain,","institution_ids":["https://openalex.org/I1307323311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016614768","display_name":"Carmen deTorres","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1307323311","display_name":"Hospital Sant Joan de D\u00e9u Barcelona","ror":"https://ror.org/001jx2139","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I1307323311"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Carmen deTorres","raw_affiliation_strings":["3Hospital Sant Joan de Deu, Barcelona, Spain,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Hospital Sant Joan de Deu, Barcelona, Spain,","institution_ids":["https://openalex.org/I1307323311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048605189","display_name":"Cinzia Emilia Lavarino","orcid":"https://orcid.org/0000-0002-9630-3676","observed_orcids":["https://orcid.org/0000-0002-9630-3676"]},"institutions":[{"id":"https://openalex.org/I4210127203","display_name":"Sant Joan de D\u00e9u Research Foundation","ror":"https://ror.org/03g7nb016","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210127203","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Cinzia Lavarino","raw_affiliation_strings":["4Sant Joan de Deu Research Foundation, Barcelona, Spain,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Sant Joan de Deu Research Foundation, Barcelona, Spain,","institution_ids":["https://openalex.org/I4210127203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049575173","display_name":"Liliana Velasco\u2010Hidalgo","orcid":"https://orcid.org/0000-0001-5882-2187","observed_orcids":["https://orcid.org/0000-0001-5882-2187"]},"institutions":[{"id":"https://openalex.org/I4210146908","display_name":"Instituto Nacional de Pediatria","ror":"https://ror.org/05adj5455","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210146908"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Liliana Velasco-Hidalgo","raw_affiliation_strings":["5National Institute of Pediatrics, Mexico City, Mexico,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5National Institute of Pediatrics, Mexico City, Mexico,","institution_ids":["https://openalex.org/I4210146908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070037867","display_name":"Roc\u00edo del Socorro C\u00e1rdenas-Cardos","orcid":"https://orcid.org/0000-0002-4390-5892","observed_orcids":["https://orcid.org/0000-0002-4390-5892"]},"institutions":[{"id":"https://openalex.org/I4210146908","display_name":"Instituto Nacional de Pediatria","ror":"https://ror.org/05adj5455","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210146908"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Rocio Cardenas-Cardos","raw_affiliation_strings":["5National Institute of Pediatrics, Mexico City, Mexico,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5National Institute of Pediatrics, Mexico City, Mexico,","institution_ids":["https://openalex.org/I4210146908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103259929","display_name":"Simone dos Santos Aguiar","orcid":"https://orcid.org/0000-0002-7545-6382","observed_orcids":["https://orcid.org/0000-0002-7545-6382"]},"institutions":[{"id":"https://openalex.org/I4210102088","display_name":"Centro Infantil Boldrini","ror":"https://ror.org/017qbxe07","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210102088"]},{"id":"https://openalex.org/I4210145213","display_name":"Dow Chemical (Brasil)","ror":"https://ror.org/04a0vqv69","country_code":"BR","type":"company","lineage":["https://openalex.org/I4210133143","https://openalex.org/I4210145213"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Simone dos Santos Aguiar","raw_affiliation_strings":["6Centro Infantil Boldrini, Sao Paulo, Brazil,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Centro Infantil Boldrini, Sao Paulo, Brazil,","institution_ids":["https://openalex.org/I4210102088","https://openalex.org/I4210145213"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029247915","display_name":"Jos\u00e9 Andr\u00e9s Yunes","orcid":"https://orcid.org/0000-0002-1316-3525","observed_orcids":["https://orcid.org/0000-0002-1316-3525"]},"institutions":[{"id":"https://openalex.org/I4210102088","display_name":"Centro Infantil Boldrini","ror":"https://ror.org/017qbxe07","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210102088"]},{"id":"https://openalex.org/I4210145213","display_name":"Dow Chemical (Brasil)","ror":"https://ror.org/04a0vqv69","country_code":"BR","type":"company","lineage":["https://openalex.org/I4210133143","https://openalex.org/I4210145213"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Jose A. Yunes","raw_affiliation_strings":["6Centro Infantil Boldrini, Sao Paulo, Brazil,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Centro Infantil Boldrini, Sao Paulo, Brazil,","institution_ids":["https://openalex.org/I4210102088","https://openalex.org/I4210145213"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014325191","display_name":"Gabriela Mercado","orcid":"https://orcid.org/0000-0003-3113-0687","observed_orcids":["https://orcid.org/0000-0003-3113-0687"]},"institutions":[{"id":"https://openalex.org/I4210110970","display_name":"National Institute of Genomic Medicine","ror":"https://ror.org/01qjckx08","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210110970"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Gabriela Mercado","raw_affiliation_strings":["7National Institute of Genomic Medicine, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7National Institute of Genomic Medicine, Mexico City, Mexico","institution_ids":["https://openalex.org/I4210110970"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088508201","display_name":"Jorge Mel\u00e9ndez-Zajgla","orcid":"https://orcid.org/0000-0002-2209-1607","observed_orcids":["https://orcid.org/0000-0002-2209-1607"]},"institutions":[{"id":"https://openalex.org/I4210110970","display_name":"National Institute of Genomic Medicine","ror":"https://ror.org/01qjckx08","country_code":"MX","type":"government","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210110970"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Jorge Melendez-Zajgla","raw_affiliation_strings":["7National Institute of Genomic Medicine, Mexico City, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7National Institute of Genomic Medicine, Mexico City, Mexico","institution_ids":["https://openalex.org/I4210110970"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068380379","display_name":"Charles W.M. Roberts","orcid":"https://orcid.org/0000-0003-1135-1896","observed_orcids":["https://orcid.org/0000-0003-1135-1896"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Roberts","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, MA,","2Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA,","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"2Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055048393","display_name":"Levi A. Garraway","orcid":"https://orcid.org/0000-0003-3739-0471","observed_orcids":["https://orcid.org/0000-0003-3739-0471"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Levi Garraway","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, MA,","2Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA,","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"2Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053318111","display_name":"Carlos Rodriguez Galindo","orcid":"https://orcid.org/0000-0002-2360-8946","observed_orcids":["https://orcid.org/0000-0002-2360-8946"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carlos Rodriguez-Galindo","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, MA,","2Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA,","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"2Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001449157","display_name":"Todd R. Golub","orcid":"https://orcid.org/0000-0003-0113-2403","observed_orcids":["https://orcid.org/0000-0003-0113-2403"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Todd Golub","raw_affiliation_strings":["1Broad Institute, Cambridge, MA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Broad Institute, Cambridge, MA,","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079784932","display_name":"Stuart H. Orkin","orcid":"https://orcid.org/0000-0002-0313-152X","observed_orcids":["https://orcid.org/0000-0002-0313-152X","https://orcid.org/0000-0002-3523-7687"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stuart Orkin","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, MA,","2Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA,","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"2Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001392592","display_name":"Gad A. Getz","orcid":"https://orcid.org/0000-0002-0936-0753","observed_orcids":["https://orcid.org/0000-0002-0936-0753"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gad Getz","raw_affiliation_strings":["1Broad Institute, Cambridge, MA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Broad Institute, Cambridge, MA,","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056053037","display_name":"Katherine A. Janeway","orcid":"https://orcid.org/0000-0001-6000-3594","observed_orcids":["https://orcid.org/0000-0001-6000-3594"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine Janeway","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston, MA,","2Dana Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston, MA,","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"2Dana Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"74","issue":"20_Supplement","first_page":"A41","last_page":"A41"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9297000169754028,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9297000169754028,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.02630000002682209,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.013299999758601189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/osteosarcoma","display_name":"osteosarcoma","score":1.0},{"id":"https://openalex.org/keywords/pi3k-mtor-pathway","display_name":"PI3K/mTOR pathway","score":0.996999979019165},{"id":"https://openalex.org/keywords/therapeutic-vulnerabilities","display_name":"therapeutic vulnerabilities","score":0.8500000238418579},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.8659999966621399},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.7179999947547913},{"id":"https://openalex.org/keywords/genomic-instability","display_name":"genomic instability","score":0.6690000295639038},{"id":"https://openalex.org/keywords/chromosomal-rearrangements","display_name":"chromosomal rearrangements","score":0.8389999866485596},{"id":"https://openalex.org/keywords/intertumoral-heterogeneity","display_name":"intertumoral heterogeneity","score":0.7300000190734863},{"id":"https://openalex.org/keywords/shrna-screen","display_name":"shRNA screen","score":0.6919999718666077},{"id":"https://openalex.org/keywords/pathway-analysis","display_name":"pathway analysis","score":0.7710000276565552},{"id":"https://openalex.org/keywords/comparative-oncology","display_name":"comparative oncology","score":0.9449999928474426},{"id":"https://openalex.org/keywords/pi3k-mtor-inhibition","display_name":"PI3K/mTOR inhibition","score":0.7519999742507935},{"id":"https://openalex.org/keywords/pediatric-bone-cancer","display_name":"pediatric bone cancer","score":0.5740000009536743}],"concepts":[{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.7538862228393555},{"id":"https://openalex.org/C2777760704","wikidata":"https://www.wikidata.org/wiki/Q549534","display_name":"Osteosarcoma","level":2,"score":0.6945810914039612},{"id":"https://openalex.org/C128526571","wikidata":"https://www.wikidata.org/wiki/Q619302","display_name":"Somatic hypermutation","level":4,"score":0.6760205030441284},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6482939124107361},{"id":"https://openalex.org/C178169997","wikidata":"https://www.wikidata.org/wiki/Q2892636","display_name":"Genome instability","level":4,"score":0.5473827719688416},{"id":"https://openalex.org/C190232843","wikidata":"https://www.wikidata.org/wiki/Q1950808","display_name":"Small hairpin RNA","level":4,"score":0.5102050304412842},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4008636474609375},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3776399791240692},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.3642348051071167},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2743874788284302},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.20933076739311218},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.08715778589248657},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.07832235097885132},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.pedcan-a41","doi":"https://doi.org/10.1158/1538-7445.pedcan-a41","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.pedcan-a41","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6800000071525574}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2125409137","https://openalex.org/W2122288770","https://openalex.org/W4242524636","https://openalex.org/W2408737264","https://openalex.org/W1969457412","https://openalex.org/W2165802059","https://openalex.org/W1995436065","https://openalex.org/W1648713449","https://openalex.org/W2013628600","https://openalex.org/W1988206311"],"abstract_inverted_index":{"Abstract":[0],"Osteosarcoma":[1,152],"is":[2],"the":[3,43,82,85,91,139,163,235,248,256],"most":[4],"common":[5,240],"primary":[6],"bone":[7],"tumor":[8,102],"and":[9,33,57,72,90,115,127,159,169],"yet":[10],"there":[11,58],"have":[12],"been":[13],"no":[14],"substantial":[15],"advances":[16],"in":[17,21,77,93,99,150,167,170,242],"treatment":[18],"or":[19],"survival":[20],"over":[22],"2":[23],"decades.":[24],"We":[25],"examined":[26],"59":[27,44],"tumor/normal":[28],"pairs":[29],"by":[30],"whole-genome,":[31],"whole-exome":[32],"RNA-Sequencing.":[34],"Only":[35],"TP53":[36],"was":[37,52],"mutated":[38],"at":[39,255],"significant":[40],"frequency":[41],"across":[42],"samples.":[45],"The":[46],"mean":[47],"non-silent":[48],"somatic":[49,64],"mutation":[50,54],"rate":[51],"1.2":[53],"per":[55,66],"megabase":[56],"were":[59,75],"a":[60,95,100,119,123,128,143,239],"median":[61],"of":[62,70,87,162,247],"231":[63],"rearrangements":[65,71],"tumor.":[67],"Complex":[68],"chains":[69],"localized":[73],"hypermutation":[74],"detected":[76],"almost":[78],"all":[79,136],"cases.":[80],"Given":[81],"inter-tumor":[83],"heterogeneity,":[84],"extent":[86],"genomic":[88,109,232],"instability":[89],"difficulty":[92],"acquiring":[94],"large":[96],"sample":[97],"size":[98],"rare":[101],"we":[103],"used":[104],"several":[105],"methods":[106],"to":[107,112,138,157],"identify":[108],"events":[110],"contributing":[111],"osteosarcoma":[113],"proliferation":[114],"survival.":[116],"Pathway":[117],"analysis,":[118],"heuristic":[120],"analytic":[121],"algorithm,":[122],"comparative":[124],"oncology":[125],"approach":[126],"genome-wide,":[129],"pooled":[130],"short":[131],"hairpin":[132],"RNA":[133],"(shRNA)":[134],"screen":[135],"point":[137],"PI3K/mTOR":[140,164,236],"pathway":[141,165,237],"as":[142,238],"potential":[144],"central":[145],"vulnerability":[146,241],"for":[147],"therapeutic":[148],"exploitation":[149],"osteosarcoma.":[151,243],"cell":[153],"lines":[154],"are":[155],"responsive":[156],"pharmacologic":[158],"genetic":[160],"inhibition":[161],"both":[166],"vitro":[168],"vivo.":[171],"Citation":[172],"Format:":[173],"Adam":[174],"Kiezun,":[175],"Jennifer":[176],"Perry,":[177],"Peter":[178],"Tonzi,":[179],"Eliezer":[180],"Van":[181],"Allen,":[182],"Scott":[183],"L.":[184],"Carter,":[185],"Sylvan":[186],"Baca,":[187],"Ami":[188],"Bhatt,":[189],"Michael":[190],"Lawrence,":[191],"Loren":[192],"Walensky,":[193],"Nikhil":[194],"Wagle,":[195],"Jaume":[196],"Mora,":[197],"Carmen":[198],"deTorres,":[199],"Cinzia":[200],"Lavarino,":[201],"Liliana":[202],"Velasco-Hidalgo,":[203],"Rocio":[204],"Cardenas-Cardos,":[205],"Simone":[206],"dos":[207],"Santos":[208],"Aguiar,":[209],"Jose":[210],"A.":[211],"Yunes,":[212],"Gabriela":[213],"Mercado,":[214],"Jorge":[215],"Melendez-Zajgla,":[216],"Charles":[217],"Roberts,":[218],"Levi":[219],"Garraway,":[220],"Carlos":[221],"Rodriguez-Galindo,":[222],"Todd":[223],"Golub,":[224],"Stuart":[225],"Orkin,":[226],"Gad":[227],"Getz,":[228],"Katherine":[229],"Janeway.":[230],"Complementary":[231],"approaches":[233],"highlight":[234],"[abstract].":[244],"In:":[245],"Proceedings":[246],"AACR":[249],"Special":[250],"Conference":[251],"on":[252],"Pediatric":[253],"Cancer":[254,272],"Crossroads:":[257],"Translating":[258],"Discovery":[259],"into":[260],"Improved":[261],"Outcomes;":[262],"Nov":[263],"3-6,":[264],"2013;":[265],"San":[266],"Diego,":[267],"CA.":[268],"Philadelphia":[269],"(PA):":[270],"AACR;":[271],"Res":[273],"2013;74(20":[274],"Suppl):Abstract":[275],"nr":[276],"A41.":[277]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2025-10-10T00:00:00"}